Have a personal or library account? Click to login
Increased expression of SHP-1 is associated with local recurrence after radiotherapy in patients with nasopharyngeal carcinoma Cover

Increased expression of SHP-1 is associated with local recurrence after radiotherapy in patients with nasopharyngeal carcinoma

Radiology and Oncology
Volume 48 (2014): Issue 1 (March 2014)
By: Gang Peng,  Rubo Cao,  Jun Xue,  Pindong Li,  Zhenwei Zou,  Jing Huang and  Qian Ding  
Open Access
|Jan 2014

References

  1. 1. Chang ET, Adami HO. The enigmatic epidemiology of nasopharyngeal carcinoma. Cancer Epidemiol Biomarkers Prev 2006; 15: 1765-77.10.1158/1055-9965.EPI-06-035317035381
    Search in Google Scholar
  2. 2. Greene FL, Page DL, Fleming ID, Fritz A. AJCC cancer staging manual. 6th edition. New York, NY: Springer; 2002.10.1007/978-1-4757-3656-4
    Search in Google Scholar
  3. 3. Lee AW, Lin JC, Ng WT. Current management of nasopharyngeal cancer. Semin Radiat Oncol 2012; 22: 233-44.10.1016/j.semradonc.2012.03.00822687948
    Search in Google Scholar
  4. 4. Wee J, Tan EH, Tai BC, Wong HB, Leong SS, Tan T, et al. Randomized trial of radiotherapy versus concurrent chemoradiotherapy followed by adjuvant chemotherapy in patients with American Joint Committee on Cancer/ International Union against cancer stage III and IV nasopharyngeal cancer of the endemic variety. J Clin Oncol 2005; 23: 6730-8.10.1200/JCO.2005.16.79016170180
    Search in Google Scholar
  5. 5. Langendijk JA, Leemans CR, Buter J, Berkof J, Slotman BJ. The additional value of chemotherapy to radiotherapy in locally advanced nasopharyngeal carcinoma: a meta-analysis of the published literature. J Clin Oncol 2004; 22: 4604-12.10.1200/JCO.2004.10.07415542811
    Search in Google Scholar
  6. 6. Kwong DL, Sham JS, Au GK, Chua DT, Kwong PW, Cheng AC, et al. Concurrent and adjuvant chemotherapy for nasopharyngeal carcinoma: a factorial study. J Clin Oncol 2004; 22: 2643-53.10.1200/JCO.2004.05.17315226332
    Search in Google Scholar
  7. 7. Lin JC, Jan JS, Hsu CY, Liang WM, Jiang RS, Wang WY. Phase III study of concurrent chemoradiotherapy versus radiotherapy alone for advanced nasopharyngeal carcinoma: positive effect on overall and progression-free survival. J Clin Oncol 2003; 21: 631-7.10.1200/JCO.2003.06.15812586799
    Search in Google Scholar
  8. 8. Chua DT, Ma J, Sham JS, Mai HQ, Choy DT, Hong MH, et al. Long-term survival after cisplatin-based induction chemotherapy and radiotherapy for nasopharyngeal carcinoma: a pooled data analysis of two phase III trials. J Clin Oncol 2005; 23: 1118-24.10.1200/JCO.2005.12.08115657403
    Search in Google Scholar
  9. 9. Čarman J, Strojan P. Nasopharyngeal carcinoma in Slovenia, 1990-2003 (results of treatment with conventional two-dimensional radiotherapy). Rep Pract Oncol Radiother 2012; 17: 71-8.10.1016/j.rpor.2012.01.002386317624377003
    Search in Google Scholar
  10. 10. Harrington K, Jankowska P, Hingorani M. Molecular biology for the radiation oncologist: the 5Rs of radiobiology meet the hallmarks of cancer. Clin Oncol 2007; 19: 561-71.10.1016/j.clon.2007.04.00917591437
    Search in Google Scholar
  11. 11. Pajonk F, Vlashia E, McBridea WH. Radiation resistance of cancer stem cells: The 4 R’s of radiobiology revisited. Stem Cells 2010; 28: 639-48.10.1002/stem.318294023220135685
    Search in Google Scholar
  12. 12. López-Ruiz P, Rodriguez-Ubreva J, Cariaga AE, Cortes MA, Colás B. SHP-1 in cell-cycle regulation. Anticancer Agents Med Chem 2011; 11: 89-98.10.2174/18715201179494115421291405
    Search in Google Scholar
  13. 13. Rodriguez-Ubreva FJ, Cariaga-Martinez AE, Cortes MA, Romero-De Pablos M, Ropero S, López-Ruiz P, et al. Knockdown of protein tyrosine phosphatase SHP-1 inhibits G1/S progression in prostate cancer cells through the regulation of components of the cell-cycle machinery. Oncogene 2010; 29: 345-55.10.1038/onc.2009.32919838216
    Search in Google Scholar
  14. 14. Tassidis H, Culig Z, Wingren AG, Härkönen P. Role of the protein tyrosine phosphatase SHP-1 in Interleukin-6 regulation of prostate cancer cells. Prostate 2010; 70: 1491-500.10.1002/pros.2118420687222
    Search in Google Scholar
  15. 15. Rodríguez-Ubreva FJ, Cariaga-Martinez AE, Cortés MA, Romero-De Pablos M, Ropero S, López-Ruiz P, et al. Knockdown of protein tyrosine phosphatase SHP-1 inhibits G1/S progression in prostate cancer cells through the regulation of components of the cell-cycle machinery. Oncogene 2010; 29: 345-55.10.1038/onc.2009.329
    Search in Google Scholar
  16. 16. Zhang Y, Hagedorn CH, Wang L. Role of nuclear receptor SHP in metabolism and cancer. Biochim Biophys Acta 2011; 1812: 893-908.10.1016/j.bbadis.2010.10.006304316620970497
    Search in Google Scholar
  17. 17. Yang S, Chen J, Guo Y, Lin H, Zhang Z, Feng G, et al. Identification of prognostic biomarkers for response to radiotherapy by DNA microarray in nasopharyngeal carcinoma patients. Int J Oncol 2012; 40: 1590-600.
    Search in Google Scholar
  18. 18. López-Ruiz P, Rodriguez-Ubreva J, Cariaga AE, Cortes MA, Colás B. SHP-1 in cell-cycle regulation. Anticancer Agents Med Chem 2011; 11: 89-98.10.2174/187152011794941154
    Search in Google Scholar
  19. 19. Pawlik TM, Keyomarsi K. Role of cell cycle in mediating sensitivity to radiotherapy. Int J Radiat Oncol Biol Phys 2004; 59: 928-42.10.1016/j.ijrobp.2004.03.00515234026
    Search in Google Scholar
  20. 20. Macaluso M, Montanari M, Cinti C, Giordano A. Modulation of cell cycle components by epigenetic and genetic events. Semin Oncol 2005; 32: 452-7.10.1053/j.seminoncol.2005.07.00916210085
    Search in Google Scholar
  21. 21. Shimura T. Acquired radioresistance of cancer and the AKT/GSK3β/cyclin D1 overexpression cycle. J Radiat Res 2011; 52: 539-44.10.1269/jrr.1109821881296
    Search in Google Scholar
  22. 22. Lopez-Ruiz P, Rodriguez-Ubreva J, Cariaga AE, Cortes MA, Colas B. SHP-1 in cell-cycle regulation. Anticancer Agents Med Chem 2011; 11: 89-98.10.2174/18715201179494115421291405
    Search in Google Scholar
  23. 23. Vinayanuwattikun C, Sriuranpong V, Tanasanvimon S, Chantranuwat P, Mutirangura A. Epithelial-specific methylation marker: a potential plasma biomarker in advanced non-small cell lung cancer. J Thorac Oncol 2011; 6: 1818-25.10.1097/JTO.0b013e318226b46f21964525
    Search in Google Scholar
  24. 24. Insabato L, Amelio I, Quarto M, Zannetti A, Tolino F, et al. Elevated expression of the tyrosine phosphatase SHP-1 defines a subset of high-grade breast tumors. Oncology 2009; 77: 378-84.10.1159/00027676520090381
    Search in Google Scholar
  25. 25. Baker SJ, Reddy EP. Targeted inhibition of kinases in cancer therapy. Mt Sinai J Med 2010; 77: 573-86.10.1002/msj.20220305877821105121
    Search in Google Scholar
  26. 26. Zhang Y, Hagedorn CH, Wang L. Role of nuclear receptor SHP in metabolism and cancer. Biochim Biophys Acta 2011; 1812: 893-908. 10.1016/j.bbadis.2010.10.006304316620970497
    Search in Google Scholar
DOI: https://doi.org/10.2478/raon-2014-0001 | Journal eISSN: 1581-3207 | Journal ISSN: 1318-2099
Journal RSS Feed
Language: English
Page range: 40 - 49
Published on: Jan 22, 2014
Published by: Association of Radiology and Oncology
In partnership with: Paradigm Publishing Services
Publication frequency: 4 issues per year
Keywords:
SHP-1,
nasopharyngeal carcinoma,
real-time quantitative PCR,
Western blotting,
immunohistochemistry,
radiation resistance
Related subjects:
Medicine,
Clinical medicine,
Internal medicine,
Haematology, oncology,
Radiology

© 2014 Gang Peng, Rubo Cao, Jun Xue, Pindong Li, Zhenwei Zou, Jing Huang, Qian Ding, published by Association of Radiology and Oncology
This work is licensed under the Creative Commons License.

Previous articleVolume 48 (2014): Issue 1 (March 2014)Next article